Ronald Bailey Argues that the FDA Should Let People Get Their Genes Tested

Earlier this week the Food and Drug
Administration sent a warning letter to the direct to consumer gene
testing company 23andMe ordering the company to stop marketing its
$99 genotype screening test. So what are the FDA’s bureaucrats
worried about? Evidently they fear that purchasers of 23andMe’s
personal genome services will do something dangerously stupid in
reaction to the genetic risk information that the tests provide.
Reason Science Correspondent Ronald Bailey points out that
the FDA has offered no evidence that 23andMe test results are going
to produce an outbreak of do-it-yourself mastectomies.

View this article.